In vitro opioid receptor assays

Current Protocols in Pharmacology

Volumn , Issue SUPPL. 55, 2011, Pages

  Taylor, David A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Delta opioid receptors; Guinea pig; In vitro assays; Kappa opioid receptors; Longitudinal muscle myenteric plexus; Mouse; Mu opioid receptors; Opioid receptors; Vas deferens

Indexed keywords

BETA ENDORPHIN; BETA FUNALTREXAMINE; BINALTORPHIMINE; BUPRENORPHINE; DIPRENORPHINE; DYNORPHIN A; DYNORPHIN B; ETORPHINE; FENTANYL; HYDROMORPHONE; ISOFLURANE; KAPPA OPIATE RECEPTOR AGONIST; LEUCINE ENKEPHALIN; METENKEPHALIN; METHADONE; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALBUPHINE; NALOXONE; NALTREXONE; NALTRINDOLE; NOCICEPTIN; NORMORPHINE; OPIATE RECEPTOR; PLACEBO; SPIRADOLINE; SUFENTANIL;

ANALGESIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CERVICAL SPINE DISLOCATION; CONCENTRATION RESPONSE; DRUG EFFICACY; DRUG SENSITIVITY; DRUG TOLERABILITY; ELECTROSTIMULATION; HUMAN; IC 50; ILEUM; IN VITRO STUDY; MUSCLE CELL; MUSCLE CONTRACTION; MYENTERIC PLEXUS; NERVE ENDING; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SMOOTH MUSCLE CONTRACTILITY; SPERMATIC CORD; STEADY STATE; SURGICAL TECHNIQUE; TARGET ORGAN; TISSUE PREPARATION; TISSUE REACTION; UREA CYCLE; VAS DEFERENS;

EID: 84255199672     PISSN: 19348282     EISSN: 19348290     Source Type: Journal    
DOI: 10.1002/0471141755.ph0408s55     Document Type: Article

References (38)

1. Akil, H., Mayer, D.J., and Liebeskind, J.C. 1976. Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science 191:961-962.
2. Akil, H., Watson, S.J., Young, E., Lewis, M.E., Khachaturian, H., and Walker, J.M. 1984. Endogenous opioids: Biology and function. Ann. Rev. Neurosci. 7:223-255.
3. Arunlakshana, O. and Schild, H.O. 1959. Some quantitative uses of drug antagonists. Brit. J. Pharmacol. 14:48-58.
4. Bertie, F., Bruno, F., Omini, C., and Racagni, G. 1978. Genotype dependent response of morphine and methionine-enkephalin on the electrically induced contractions of the mouse vas deferens. Naunyn Schmiedebergs Arch. Pharmacol. 305:5-8.
5. Berzetei-Gurske, I.P., White, A., Polgar, W., De-Costa, B.R., Pasternak, G.W., and Toll, L. 1995. The in vitro pharmacological characterization of naloxone benzoylhydrazone. Eur. J. Pharmacol. 277:257-263.
6. Cal'o, G., Rizzi, A., Bogoni, G., Neugebauer, V., Salvadori, S., Guerrine, R., Bianchi, C., and Regoli, D. 1996. The mouse vas deferens: A pharmacological preparation sensitive to nociceptin. Eur. J. Pharmacol. 311:R3-R5.
7. Cherubini, E. and North, R.A. 1985. Mu and kappa opioids inhibit transmitter release by different mechanisms. Proc. Natl. Acad. Sci. U.S.A. 82:1860-1863.
8. Corbett, A.D., Henderson, G., McKnight, A.T., and Paterson, S.J. 2006. 75 years of opioid research: The exciting but vain quest for the Holy Grail. Brit. J. Pharmacol. 147:S153-S162.
9. Donovan, J. and Brown, P. 1998. Anesthesia. Curr. Protoc. Immunol. 27:1.4.1-1.4.5.
10. Donovan, J.D. and Brown, P. 2006. Euthanasia. Curr. Protoc. Immunol. 73:1.8.1-1.8.4.
11. Fleming, W.W., Westfall, D.P., de la Lande, I.S., and Jellett, L.B. 1972. Log-normal distribution of equieffective doses of norepinephrine and acetylcholine in several tissues. J. Pharmacol. Exp. Ther. 181:339-345.
12. Frigeni, V., Bruno, F., Carenzi, A., and Racagni, G. 1981. Difference in the development of tolerance to morphine and D-Ala2-Methionineenkephalin in C57 BL/6J and DBA/2Jmice. Life Sci. 28:729-736.
13. Goldstein, A. and Schulz, R. 1973. Morphinetolerant longitudinal muscle strip from guineapig ileum. Brit. J. Pharmacol. 48:655-666.
14. Goldstein, A., Lowney, L.I., and Pal, B.K. 1971. Stereospecific and nonspecific interactions of the morphine congener Levorphanol in subcellular fractions of mouse brain. Proc. Natl. Acad. Sci. U.S.A. 68:1742-1747.
15. Henderson, G. and Hughes, J. 1976. The effects of morphine on the release of noradrenaline from the mouse vas deferens. Brit. J. Pharmacol. 57:551-557.
16. Henderson, G., Hughes, J., and Kosterlitz, H.W. 1972. A new example of a morphine sensitive neuro-effector junction: Adrenergic transmission in the mouse vas deferens. Brit. J. Pharmacol. 46:764-766.
17. Hughes, J., Kosterlitz, H.W., and Leslie, F.M. 1975. Effect of morphine on adrenergic transmission in the mouse vas deferens: Assessment of agonist and antagonist potencies of narcotic analgesics. Brit. J. Pharmacol. 53:371-381.
18. Johnson, S.M., Westfall, D.P., Howard, S.A., and Fleming, W.W. 1978. Sensitivities of the isolated ileal longitudinal smooth muscle-myenteric plexus and hypogastric nerve-vas deferens of the guinea-pig after chronic morphine pellet implantation. J. Pharmacol. Exp. Ther. 204:54-66.
19. Knapp, R.J., Vaughn, L.K., and Yamamura, H.I. 1995. Selective ligands for μ and δ opioid receptors. In The Pharmacology of Opioid Peptides (L.F. Tseng, ed.) pp. 1-28. Harwood Academic Publishers, Singapore.
20. Kosterlitz, H.W. andWaterfield, A.A. 1975. In vitro models in the study of structure-activity relationships of narcotic analgesics. Annu. Rev. Pharmacol. 15:29-47.
21. Johnson, S.M. and Fleming, W.W. 1989. Mechanisms of cellular adaptive sensitivity changes: Applications to opioid tolerance and dependence. Pharm. Rev. 41:435-488.
22. Leedham, J.A., Bennett, L.E., Taylor, D.A., and Fleming, W.W. 1991. Involvement of mu, delta and kappa receptors in morphineinduced tolerance in the guinea pig myenteric plexus. J. Pharmacol. Exp. Ther. 259:295-301.
23. Lord, J.A.H., Waterfield, A.A., Hughes, J., and Kosterlitz, H.W. 1977. Endogenous opioid peptides: Multiple agonists and receptors. Nature 267:495-499.
24. Maldonado, R., Severini, C., Matthes, H.W.D., Kieffer, B.L., Melchiorri, P., and Negri, L. 2001. Activity of mu- and delta-opioid agonists in vas deferens frommice deficient inMOR gene. Brit. J. Pharm. 132:1485-1492.
25. Martin, W.R. 1967. Opioid Antagonists. Pharm. Rev. 19:463-521.
26. Martin, W.R., Eades, C.G., Fraser, H.F., and Winkler, A. 1964. Use of hindlimb reflexes of the chronic spinal dog for comparing analgesics. J. Pharmacol. Exp. Ther. 144:8-11.
27. Martin, W.R., Eades, C.G., Thompson, J.A., Huppler, R.E., and Gilbert, P.E. 1976. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:517-532.
28. Miller, L. and Shaw, J.S. 1984. Mu-receptors in the C57BL mouse vas deferens. Life Sci. 5:93-96.
29. Mosberg, H.I., Hurst, R., Hruby, V.J., Gee, K., Yamamura, H.I., Galligan, J.J., and Burks, T.F. 1983. Bis-penicillamine enkephalins possess highly improved specificity toward δ opioid receptors. Proc. Natl. Acad. Sci. U.S.A. 80:5871-5874.
30. Paton, W.D.M. and Vizi, E.S. 1969. The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip. Brit. J. Pharmacol. 35:10-29.
31. Pert, C.B. and Snyder, S.H. 1973. Opiate receptor: Demonstration in nervous tissue. Science 179:1011-1014.
32. Portoghese, P.S. 1965. A new concept on the mode of interaction of narcotic analgesics with receptors. J. Med. Chem. 8:609-616.
33. Simon, E.J., Hiller, J.M., and Edelman, I. 1973. Stereospecific binding of the potent narcotic analgesic 3H-etorphine to rat brain homogenate. Proc. Natl. Acad. Sci. U.S.A. 70:1947-1949.
34. Smith, J.A. and Leslie, F.M. 1993. Use of organ systems for opioid bioassay. In Handbook of Experimental Pharmacology, Vol. 104/I (A. Herz, H. Akil, and E. Simon, eds.) pp. 53-78. Springer-Verlag, Berlin.
35. Surprenant, A. and North, R.A. 1985. μ-Opioid receptors and α2-adrenoceptors coexist on myenteric but not on submucous neurons. Neuroscience 16:425-430.
36. Taylor, D.A. and Fleming, W.W. 2001. Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J. Pharmacol. Exp. Ther. 297:11-18.
37. Terenius, L. 1973. Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat brain cortex. Acta Pharmacol. Toxicol. 32:317-320.
38. Waterfield, A.A., Lord, J.A.H., Hughes, J., and Kosterlitz, H.W. 1978. Differences in the inhibitory effects of normorphine and opioid peptides on the responses of the vasa deferentia of two strains of mice. Eur. J. Pharmacol. 47:249-250.